|
|
 |
|
|
"Health Care Policy, a Changing
Market, and Prospects for Biotech"
April 15, 2004
Lehigh University
College of Business and Economics
Rauch Business Center
621 Taylor Street
Bethlehem, PA 18105
|
Agenda
|
|
1:30 p.m.
|
Welcome
Roland K. Yoshida - Provost, Lehigh University
|
|
1:45 p.m.
|
Keynote address -
"Health Care Policy and Reimbursement in the U.S. - Paying for Drugs: Who Pays and How Much?"
Robert J. Rubin, MD - Clinical Professor of Medicine in the Division of Nephrology and Hypertension, Georgetown University School of Medicine
|
|
2:30 p.m.
|
Panel 1
Topic: "The Impact of Pharmaceutical Policy on Investors in Biotech Firms"
| Moderator: |
Brenda D. Gavin, D.V.M - Managing Partner, Quaker BioVentures |
| Panelists: |
Dan Omstead, Eng.ScD - President and CEO, Hambrecht & Quist Capital Management |
|
Elaine V. Jones, PhD - General Partner, EuclidSR Partners |
|
|
3:45 p.m.
|
Break
|
|
4:00 p.m.
|
Keynote address -
"Competition, Innovation, and Access to Pharmaceuticals in the United States and Europe: Comparative Perspectives"
Jeffrey Sturchio, PhD - Vice President, External Affairs, Human Health - Europe, Middle East, and Africa, Merck & Co., Inc.
|
|
4:45 p.m.
|
Panel 2
Topics: Pharmaceutical Reimbursement and its Effects on Generic Strategies
| Moderator: |
Peter West, PhD - Director, Health Economics Consortium, University of York (UK) |
| Panelists: |
Barry Edwards - CEO, Impax Labs Inc. |
|
William A. Fletcher - President and CEO, Teva North America |
|
|
6:00 p.m.
|
Reception
|
|
6:45 p.m.
|
Dinner
|
»Click here for the main page«
|
|
|
|
|
